Researchers accidentally formed gold hydride under extreme pressure, revealing that gold is actually a "reactive metal." ...

Scientists predict new carbon-hydrogen matter state that conducts electricity directionally under extreme pressures found in ...

For a century, superconductivity has been something physicists find, not something they build. Strain engineering in ...

GUANGZHOU -- Chinese scientists have uncovered a crucial mechanism explaining how Earth may have stored vast quantities of water in its infancy, shedding new light on the planet's dramatic evolution ...

Researchers have used artificial intelligence to predict dozens of previously unknown carbon crystal structures, including at least one with a calculated hardness exceeding that of diamond. The ...

Scientists have set a new record for superconductivity at normal pressure, bringing the field closer to practical, real-world applications.

Superconductors are materials that conduct electricity with an electrical resistance of zero. Superconductivity is generally observed when materials are cooled down to extremely low temperatures. In ...

Jake Fillery is an Evergreen Editor for GameRant who has been writing lists, guides, and reviews since 2022. With thousands of engaging articles and guides, Jake loves conversations surrounding all ...

Superconductivity is the ability to transmit energy without any resistance when an object is cooled to a certain temperature. For more than 30 years, that temperature was 220 degrees Fahrenheit below ...

The Large Hadron Collider at CERN uses superconducting magnets to accelerate and direct a particle beam. Discovery of superconductors that work at (or close to) room temperatures would represent a ...

When so much of our days are filled with scrolling, streaming, listening and email-sending, it’s easy to forget that there are hobbies that don’t actually require a screen. The great thing about ...

(RTTNews) - Black Diamond Therapeutics, Inc. (BDTX) will host a webcast presentation on December 3, 2025, at 8:00 am ET to highlight results from its ongoing Phase 2 clinical trial of silevertinib in ...